A revolution in the treatment and rehabilitation of muscle/tendon injuries is on its way with the development of a ground-breaking new intelligent technology developed at Griffith University and the University of Auckland.
Called iTraining, the biomedically engineered system works in real time to provide feedback on the stresses and strains that affect a specific muscle or tendon, either following injury or in the prevention of injury.
Following the award of a grant of nearly $1m from Australian Research Council and industry partners, Professor David Lloyd, from Griffith’s Menzies Health Institute Queensland, and other colleagues are now preparing to undertake a large three-part study that will focus on the Achilles tendon.
“Currently the mechanical environment of the Achilles tendon is poorly understood because of difficulties associated with directly measuring the stresses and strains experienced throughout the tendon in daily activities. If these issues can be overcome, it will be possible to identify the loading conditions required to facilitate favourable structural and mechanical adaption of healthy, as well as injured or diseased Achilles tendons,” says Professor Lloyd.
Potential to radically transform
“The technology to achieve this goal is now within reach and has the potential to radically transform the way athletic training and rehabilitation programs for the Achilles tendon are designed and monitored.
“The approach will allow the trainer to identify an individual’s optimal loading conditions for positive structural and mechanical adaption of their Achilles tendon, by using methods that integrate the necessary technologies to measure stress-strain of the tendon in real time.”
The study will be broken into three parts. Part A will aim to determine the optimal loading conditions required to alter the structural, mechanical and biochemical properties of the Achilles tendon; Part B will be to develop the iTraining system which will entail participants wearing next generation wearable sensors coupled with computer models, to provide real-time biofeedback of the tendon’s mechanical behaviour; Part C will determine the efficacy of an iTraining program to alter the structural properties of the human Achilles tendon.
Professor Lloyd says the iTraining approach will be likely to have broad application to other tendons and musculoskeletal tissues within the body.
“This new ‘intelligent’ approach to training and rehabilitation is at the forefront of modern developments in biomechanics, rehabilitation engineering, sports science and sports medicine.
“iTraining has the potential to radically transform the practice of exercise prescription across the full spectrum from elite performance to rehabilitation of acute and chronic musculoskeletal conditions,” he says.
“A key feature of this approach is that feedback is subject specific and therefore consistent with the concept of the ‘quantitative’ self and the trend in science and practice is of course, to move towards models of personalised medicine and rehabilitation.”
Professor Lloyd says he envisages that the technology could be available in public gyms and physiotherapy practices in as little as four years.
The Latest on: Personalised medicine
[google_news title=”” keyword=”personalised medicine” num_posts=”10″ blurb_length=”0″ show_thumb=”left”]
via Google News
The Latest on: Personalised medicine
- Personalized Medicine Market Size to Surpass USD 1,233.23 Bn by 2033on February 22, 2024 at 8:15 am
The global personalized medicine market size is expected to surpass around USD 1,233.23 billion by 2033, increasing from USD 578.21 billion in 2023, According to .Ottawa, Feb. 22, 2024 (GLOBE NEWSWIRE ...
- New cancer research for personalized careon February 22, 2024 at 5:38 am
These findings are expected to streamline the process of matching an immunotherapy treatment to a specific patient since it is very important to identify in advance those patients who will react to a ...
- Long Read Sequencing Market to Reach $5,142.3 Million by 2030 Owing To Increasing Demand for Personalized Medicine | Says Coherent Market Insightson February 20, 2024 at 1:04 am
Burlingame, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Coherent Market Insights published a report, titled, Global Long Read Sequencing Market, By Technology (Single Molecule Real-Time (SMRT) Sequencing, ...
- Why India’s first comprehensive healthy microbiome map can aid personalised medicineon February 19, 2024 at 9:12 pm
Almost 90% of the known human diseases are associated with microbiomes with human body housing trillions of them ...
- Unlocking the Potential of AI-Driven Biomarkers: A New Era in Personalized Cancer Careon February 15, 2024 at 9:46 am
As we witness the emergence of more treatments, personalized medicine becomes crucial to tailoring therapies to each individual patient. However, the lack of effective cancer treatment-specific ...
- Researchers edge closer to delivering personalized medicine to cancer patientson February 14, 2024 at 3:59 am
For the first time, Purdue researchers prove that measuring mechanical motions in living cancer tissues is a viable and promising approach for predicting chemoresistance ...
- UK Agency targets blood thinners in personalised medicine pursuiton February 13, 2024 at 11:29 am
The MHRA kicks off phase two of the Yellow Card biobank to explore the genetic link to side effects of direct oral anticoagulants.
- Purdue researchers edge closer to delivering personalized medicine to cancer patientson February 13, 2024 at 8:48 am
Chemotherapy can save lives, but often a cancer patient may be resistant to their prescribed chemotherapy, which costs the patient valuable time. Chemoresistance is a topic that researchers need to ...
- AI Pioneer GEDi Cube and Biotech Innovator Renovaro Biosciences Combine Forces to Accelerate Personalized Medicineon February 13, 2024 at 7:31 am
Renovaro Inc. (NASDAQ: RENB) announced today that it completed its acquisition of GEDi Cube Intl Ltd. (“GEDiCube”). Renovaro, which means renew, combines the power of the AI Health Tech platform of ...
- Precision Medicine Tool May Personalize Pediatric Cancer Treatmenton February 13, 2024 at 5:00 am
A new pharmacology platform designed to shed light on drug dynamics in pediatric cancer patients could help clinicians better personalize treatment plans.
via Bing News